Skip to main content

Serge Osula, MBBS, MRCP

Teaching Collection
08/01/2008
In-stent restenosis (ISR) is a difficult complication to treat, occurring in 15–35% of stents deployed for de novo lesions in native coronary arteries.1,2 The restenosis rate following therapy for ISR is as high as 54%.3 Thus far, there is...
In-stent restenosis (ISR) is a difficult complication to treat, occurring in 15–35% of stents deployed for de novo lesions in native coronary arteries.1,2 The restenosis rate following therapy for ISR is as high as 54%.3 Thus far, there is...
In-stent restenosis (ISR) is a...
08/01/2008
Journal of Invasive Cardiology